Ascentage Financial Statements From 2010 to 2025
| ASPHF Stock | USD 8.48 0.00 0.00% |
Check Ascentage Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ascentage Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ascentage financial statements analysis is a perfect complement when working with Ascentage Pharma Valuation or Volatility modules.
Ascentage |
Ascentage Pharma Group Company Shares Outstanding Analysis
Ascentage Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Ascentage Pharma Shares Outstanding | 287.77 M |
Most of Ascentage Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ascentage Pharma Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Ascentage Pharma Group has 287.77 M of shares currently outstending. This is 59.4% higher than that of the Healthcare sector and 169.31% higher than that of the Biotechnology industry. The shares outstanding for all United States stocks is 49.68% higher than that of the company.
Ascentage Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ascentage Pharma's current stock value. Our valuation model uses many indicators to compare Ascentage Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ascentage Pharma competition to find correlations between indicators driving Ascentage Pharma's intrinsic value. More Info.Ascentage Pharma Group is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ascentage Pharma's earnings, one of the primary drivers of an investment's value.About Ascentage Pharma Financial Statements
Ascentage Pharma stakeholders use historical fundamental indicators, such as Ascentage Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ascentage Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ascentage Pharma's assets and liabilities are reflected in the revenues and expenses on Ascentage Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ascentage Pharma Group. Please read more on our technical analysis and fundamental analysis pages.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Additional Information and Resources on Investing in Ascentage Pink Sheet
When determining whether Ascentage Pharma is a strong investment it is important to analyze Ascentage Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascentage Pharma's future performance. For an informed investment choice regarding Ascentage Pink Sheet, refer to the following important reports:Check out the analysis of Ascentage Pharma Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.